4//SEC Filing
Drexler Ryan Charles 4
Accession 0001493152-21-020490
CIK 0001415684other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 9:56 PM ET
Size
5.7 KB
Accession
0001493152-21-020490
Insider Transaction Report
Form 4
MusclePharm CorpMSLP
Drexler Ryan Charles
Director10% Owner
Transactions
- Other
Convertible Promissory Note
2021-08-13Exp: 2022-07-14→ Common Stock
Footnotes (3)
- [F1]On October 15, 2020, Mr. Drexler entered into a convertible secured promissory note agreement with a principal amount of $2,457,549 with the Company. (the "October 2020 Convertible Note"). Both the principal and any accrued but unpaid interest under the October 2020 Convertible Note will become due and payable on July 14, 2022, unless earlier converted or repaid.
- [F2]Closing price on October 15, 2021
- [F3]Determined on October 15, 2021
Documents
Issuer
MusclePharm Corp
CIK 0001415684
Entity typeother
Related Parties
1- filerCIK 0001648033
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 9:56 PM ET
- Size
- 5.7 KB